Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

B

Bispebjerg Hospital

Status and phase

Unknown
Phase 2

Conditions

Photodynamic Therapy
Basal Cell Carcinomas

Treatments

Procedure: Daylight mediated photodynamic therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT01349361
2010-024517-31

Details and patient eligibility

About

Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • superficial BCC

Exclusion criteria

  • Immunosuppression

Trial design

0 participants in 1 patient group

Daylight-PDT
Experimental group
Treatment:
Procedure: Daylight mediated photodynamic therapy

Trial contacts and locations

1

Loading...

Central trial contact

Stine R Wiegell, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems